Skip to main content
. Author manuscript; available in PMC: 2024 Jul 1.
Published in final edited form as: Lancet HIV. 2023 Jun 8;10(7):e461–e471. doi: 10.1016/S2352-3018(23)00085-1

Table 2.

Population HIV prevalence estimates among Venezuelan migrants and refugees overall and within subgroups in four cities of Colombia (N=6,221)

Sample proportion Population estimate
n % % 95%CI:
HIV prevalence overall 71 1.1 0.9 (0.6–1.4)
Site
Bogotá & Soacha (n=3,102) 28 0.9 0.8 (0.4–1.5)
Barranquilla & Soledad (n=3,118) 43 1.4 1.2 (0.7–2.0)
Age
18 to 30 (n=2,470) 29 1.2 0.8 (0.5–1.4)
30 to 39 (n=1,978) 26 1.3 1.1 (0.6–2.2)
40 to 49 (n=1,024) 9 0.9 0.4 (0.2–0.9)
50+ (n=748) 7 0.9 1.5 (0.3–6.6)
Gender
Man (n=2,123) 41 1.9 1.6 (0.9–2.6)
Woman (n=4,046) 26 0.6 0.6 (0.2–1.2)
Transgender/Nonbinary (n=47) 4 8.5 -- --
Migration status
Regular (n=1,779) 26 1.5 1.4 (0.8–2.5)
Irregular (n=4,442) 45 1.0 0.7 (0.4–1.4)
Syphilis infection (n=324) 17 5.3 7.0 (2.6–3.4)
Key population (n=407) 27 6.7 6.4 (3.5–11.5)
Men who have sex with men (n=207) 23 11.1 9.5 (4.9–17.7)
Ever paid for sex (n=82) 3 3.7 2.2 (0.6–7.7)
Lifetime transactional sex (n=106) 7 6.6 3.2 (1.3–7.4)
Lifetime injecting drug use (n=130) 3 2.3 0.8 (0.2–2.7)

Notes: n: denominator for subgroup; N: total study population; 95%CI: 95% Confidence Interval; Ref: reference group not displayed; Population estimates were not calculated for transgender participants due to the small sample size; Key population was defined as individuals who identify within at least one of the following groups: transgender or nonbinary gender people, men who have sex with men, individuals who report lifetime transactional sex, and/or report lifetime injecting drug use.